Stock Events

Stock Events

Seelos Therapeutics 

0
0
+€0.00+0% 00:00 Today

Statistics

Day High
-
Day Low
-
52W High
-
52W Low
-
Volume
-
Avg. Volume
-
Mkt Cap
0
P/E Ratio
-
Dividend Yield
-
Dividend
-

Financials

-1,698.04%Profit Margin
Unprofitable
2018
2019
2020
2021
2022
2023
2.03MRevenue
-34.39MNet Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow NXEN.MU. It's not an investment recommendation.
Microsoft
2
MSFT
Amazon
2
AMZN
Alphabet
2
GOOGL
ASML NV
2
ASML

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Axsome Therapeutics
AXSM
Mkt Cap10.42B
Axsome Therapeutics develops novel therapies for central nervous system disorders, similar to Seelos' focus, making them direct competitors.
Alkermes
ALKS
Mkt Cap7.95B
Alkermes plc works on developing innovative medicines for neurological and psychiatric disorders, overlapping with Seelos' therapeutic areas.
BridgeBio Pharma
BBIO
Mkt Cap14.97B
BridgeBio Pharma targets genetic diseases and genetically defined cancers, including neurological disorders, competing in the same innovative therapeutic area as Seelos.
Biogen
BIIB
Mkt Cap32.28B
Biogen focuses on neurology, making it a competitor by developing treatments for diseases in similar domains as Seelos.
AMGEN
AMGN
Mkt Cap233.78B
Amgen's broad focus on innovative therapeutics includes neurological conditions, positioning it as a competitor to Seelos.
Novartis
NVS
Mkt Cap292.35B
Novartis offers a wide range of healthcare solutions, including treatments for neurological conditions, making it a competitor in the same market as Seelos.
Pfizer
PFE
Mkt Cap159.36B
Pfizer has a diverse portfolio that includes treatments for neurological disorders, competing with Seelos in the broader pharmaceutical market.
Johnson & Johnson
JNJ
Mkt Cap645.95B
Johnson & Johnson, through its pharmaceutical division Janssen, develops treatments for neurological and mental disorders, competing with Seelos.
Merck
MRK
Mkt Cap366B
Merck & Co., Inc. has a diversified portfolio that includes drug development for neurological diseases, making it a competitor in the same therapeutic area as Seelos.

About

SEELOS THERAPEUTICS INC
Show more...
CEO
Country
United States
ISIN
US81577F1093
WKN
000A40Q45

Listings

OTC Link
US
SEELQ
MU
DE
NXEN.MU
STU
DE
NXE.STU
MU
DE
NXE.MU

0 Comments

Share your thoughts

FAQ

What is Seelos Therapeutics stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on Boerse Muenchen exchange Seelos Therapeutics stocks are traded under the ticker NXEN.MU.
What is Seelos Therapeutics revenue for the last year?▼
Seelos Therapeutics revenue for the last year amounts to 2.03M EUR.
What is Seelos Therapeutics net income for the last year?▼
NXEN.MU net income for the last year is -34.39M EUR.
In which sector is Seelos Therapeutics located?▼
Seelos Therapeutics operates in the Other sector.
When did Seelos Therapeutics complete a stock split?▼
The last stock split for Seelos Therapeutics was on November 28, 2023 with a ratio of 1:30.